Physicians’ Education Resource® to Host Virtual Tumor Board®: Diagnosis and Management of Polycythemia Vera and Myelofibrosis, a Live Video Webcast

This live webcast will provide the latest insights on five patient
cases with polycythemia vera (PV) or myelofibrosis (MF).

CRANBURY, N.J.–(BUSINESS WIRE)–Physicians’ Education Resource® (PER®), a leading resource for
continuing medical education (CME), will present an interactive live
video webcast entitled Virtual Tumor Board® titled “Diagnosis and
Management of Polycythemia Vera and Myelofibrosis” Thursday, Feb. 21, at
8 p.m. EST. The tumor board will be chaired by Ronald Hoffman, M.D.,
Albert A. and Vera G. List professor of medicine, hematology and medical
oncology and director of the myeloproliferative disorders research
program at Icahn School of Medicine at Mount Sinai.

“We are excited to present this new CME-certified ‘virtual’ activity
that incorporates real-world case scenarios of patients with
myeloproliferative neoplasms (MPNs),” said Phil Talamo, president of PER®.
“Attendees who participate in the webcast will gain expert insights
into new treatments for myelofibrosis and polycythemia vera, and how to
leverage evidence-based treatment strategies in specific clinical
situations across MPNs.”

During this live CME-certified educational webcast, Hoffman, along with
faculty expert Gillian Sanchez, MPH, BSN, RN, clinical research
program manager for the adult leukemia program at the Icahn School of
Medicine, will explore trends in the prognostic scoring, molecular
diagnostic studies and appropriate guideline-based management of MPNs,
as well as current and emerging therapeutic strategies across MPNs.

This live webcast is accredited by the Accreditation Council for
Continuing Medical Education for 1.5 AMA PRA Category 1 Credits™ for
physicians. For more information and to register, click here.

About Physicians’ Education Resource®

Since 1995, PER® has been dedicated to advancing cancer care
through professional education and now furthers patient care and
treatment strategies on a wide variety of chronic illnesses and
diseases. In 2016, PER® initiated CME programming in the
cardiovascular and endocrinology areas. While continuing to expand into
topics outside of oncology, PER® remains the leading provider
of live, online and print CME activities related to oncology and
hematology. The high-quality, evidence-based activities feature leading
distinguished experts who focus on the application of practice-changing
advances. PER® is accredited by the Accreditation Council for
Continuing Medical Education and the California Board of Registered
Nursing. PER® is part of the Cranbury, New Jersey-based MJH
Associates Inc. family of businesses. Learn more at http://www.gotoper.com
and http://www.mjhassoc.com.

Contacts

PER® Media
Alexandra Ventura, 609-716-7777, ext. 121
aventura@mjhassoc.com

John
Patricolo, 609-325-4630
jpatricolo@mjhassoc.com